MAP3K15 variant found to be a potential target for managing diabetes
Delivery route for gender affirmation treatment may affect heart health
17 November 2022What psychology tells us about the failure of the emergency services at the Manchester Arena bombing
17 November 2022MAP3K15 variant found to be a potential target for managing diabetes
A team of researchers at AstraZeneca, working with colleagues from the University of Mexico and the University of Oxford, has found that a protein tied to the MAP3K15 gene variant may represent a potential target for managing both type I and type II diabetes. The paper is published in the journal Science Advances.
